The scientists’ findings are in line with a preliminary assessment by the US Food and Drug Administration (FDA) earlier this year. The Americans also found no evidence of a causal relationship.
In fact, the same US study found that people taking semaglutide – the drug in Ozempic – had a lower risk of suicidal thoughts than those taking older drugs to treat diabetes and obesity.
However, it is not excluded that there “could be a small risk” that there is a connection. Both authorities (the EMA and the FDA) indicate that they will continue to study the subject.
2024-04-13 18:13:00
#demonstrable #link #Ozempic #thoughts #suicide #European #Medicines #Agency
